anti-BAG3 humanized mAbs (Intrepida)

N/A

Report date: 2025/06/11 10:20:48

Base Information

Drug Nameanti-BAG3 humanized mAbs (Intrepida)
Drug Alias Nameanti-BAG3 mAbs (BioUniverSa)IB-001 (Intrepida)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionBAG family molecular chaperone regulator 3 inhibitors
TargetsBAG family molecular chaperone regulator 3
Therapy Area/IndicationsPancreatic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioUniverSa Srl
China Registration ClassN/A

Develop Information

Active CompaniesIntrepida Bio Inc
Inactive CompaniesBioUniverSa Srl
Active IndicationsPancreatic Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A